FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling

Published:2021-01 Issue:1 Volume:1868 Page:118877
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Shi Yujie,Ma Zhikun,Cheng Qiong,Wu Yudan,Parris Amanda B.,Kong Lingfei,Yang Xiaohe

Funder

National Institute on Alcohol Abuse and Alcoholism

National Institute on Minority Health and Health Disparities

National Cancer Instiute

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference53 articles.

1. Metformin and reduced risk of cancer in diabetic patients;Evans;BMJ,2005

2. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis;DeCensi;Cancer Prev. Res.,2010

3. Diabetes and cancer: a consensus report;Giovannucci;Diabetes Care,2010

4. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer;Jiralerspong;J. Clin. Oncol.,2009

5. Repurposing old drugs to chemoprevention: the case of metformin;Heckman-Stoddard;Semin. Oncol.,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigation of gestational diabetes-induced endothelial dysfunction through FGF21-NRF2 pathway activation involving L-Cystine;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Identification of mechanism of the oncogenic role of FGFR1 in papillary thyroid carcinoma;European Journal of Histochemistry;2024-07-22

3. Metformin reduces basal subpopulation and attenuates mammary epithelial cell stemness in FVB/N mice;Frontiers in Cell and Developmental Biology;2024-07-11

4. NT157 as an Anticancer Drug Candidate That Targets Kinase- and Phosphatase-Mediated Signaling;Kinases and Phosphatases;2024-05-29

5. Exploring FGFR signaling inhibition as a promising approach in breast cancer treatment;International Journal of Biological Macromolecules;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3